197 related articles for article (PubMed ID: 17108211)
1. Circulating DNA and DNase activity in human blood.
Tamkovich SN; Cherepanova AV; Kolesnikova EV; Rykova EY; Pyshnyi DV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2006 Sep; 1075():191-6. PubMed ID: 17108211
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical assay for deoxyribonuclease activity in body fluids.
Cherepanova A; Tamkovich S; Pyshnyi D; Kharkova M; Vlassov V; Laktionov P
J Immunol Methods; 2007 Aug; 325(1-2):96-103. PubMed ID: 17618645
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of DNase I, a genetic marker already used for forensic identification.
Yasuda T; Kawai Y; Ueki M; Kishi K
Leg Med (Tokyo); 2005 Jul; 7(4):274-7. PubMed ID: 15946886
[TBL] [Abstract][Full Text] [Related]
5. Development of a sensitive enzyme-linked immunosorbent assay for measurement of DNase I in human serum.
Nakajima T; Takagi R; Tajima Y; Makita C; Kominato Y; Kuribara J; Ohshima S; Tada H; Tsurugaya H; Kobayashi Y; Takeshita H; Kawai Y; Yasuda T
Clin Chim Acta; 2009 May; 403(1-2):219-22. PubMed ID: 19306861
[TBL] [Abstract][Full Text] [Related]
6. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
7. Cell-surface-bound circulating DNA as a prognostic factor in lung cancer.
Tamkovich SN; Litviakov NV; Bryzgunova OE; Dobrodeev AY; Rykova EY; Tuzikov SA; Zav'ialov AA; Vlassov VV; Cherdyntseva NV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():214-7. PubMed ID: 18837949
[TBL] [Abstract][Full Text] [Related]
8. Impaired deoxyribonuclease activity in monoglandular and polyglandular autoimmunity.
Dittmar M; Poppe R; Bischofs C; Fredenhagen G; Kanitz M; Kahaly GJ
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):387-91. PubMed ID: 17701885
[TBL] [Abstract][Full Text] [Related]
9. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods.
Rykova EY; Wunsche W; Brizgunova OE; Skvortsova TE; Tamkovich SN; Senin IS; Laktionov PP; Sczakiel G; Vlassov VV
Ann N Y Acad Sci; 2006 Sep; 1075():328-33. PubMed ID: 17108228
[TBL] [Abstract][Full Text] [Related]
11. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
12. Colorimetric determination of DNase I activity with a DNA-methyl green substrate.
Sinicropi D; Baker DL; Prince WS; Shiffer K; Shak S
Anal Biochem; 1994 Nov; 222(2):351-8. PubMed ID: 7864358
[TBL] [Abstract][Full Text] [Related]
13. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
14. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
15. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
Board RE; Williams VS; Knight L; Shaw J; Greystoke A; Ranson M; Dive C; Blackhall FH; Hughes A
Ann N Y Acad Sci; 2008 Aug; 1137():98-107. PubMed ID: 18837931
[TBL] [Abstract][Full Text] [Related]
16. A new individualization marker of sweat: deoxyribonuclease I (DNase I) polymorphism.
Yasuda T; Takeshita H; Sawazaki K; Nadano D; Iida R; Miyahara S; Kishi K
J Forensic Sci; 1996 Sep; 41(5):862-4. PubMed ID: 8789848
[TBL] [Abstract][Full Text] [Related]
17. [Circulating nucleic acids in blood of patients with stomach and colon neoplasms].
Tamkovich SN; Bryzgunova OE; Rykova EIu; Kolesnikova EV; Shelestiuk PI; Laktionov PP; Vlasov VV
Biomed Khim; 2005; 51(3):321-8. PubMed ID: 16104395
[TBL] [Abstract][Full Text] [Related]
18. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
19. [Haemodynamic role of blood-plasma circulating cell-free DNA and contained therein high-molecular-weight CpG-rich fraction in pathogenesis of arterial hypertension and atherosclerosis obliterans of carotid arteries].
Konorova IL; Veĭko NN; Ershova ES; Antelava AL; Chechetkin AO
Angiol Sosud Khir; 2009; 15(2):19-28. PubMed ID: 19806935
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.
Alekseeva LA; Mironova NL; Brenner EV; Kurilshikov AM; Patutina OA; Zenkova MA
PLoS One; 2017; 12(2):e0171988. PubMed ID: 28222152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
